Safety Profile

Well tolerated in both acute and chronic therapy.

Suicide/Overdose

Precautions

Folic acid, when administered in daily doses above 0.1mg, may obscure the detection of B12 deficiency (specifically, the administration of folic acid may reverse the hematological manifestations of B12 deficiency, including pernicious anemia, while not addressing the neurological manifestations). L-methylfolate may be less likely than folic acid to mask vitamin B12 deficiency.38,39 Folate therapy alone is inadequate for the treatment of a B12 deficiency.

Folic acid, when administered in daily doses above 800 mg, may increase the amount of unmetabolized folic acid1, which has been linked to accelerated growth of existing neoplasms in the colon. L-methylfolate may be less likely than folic acid to accelerate the growth of existing neoplasms.40,41,42

Drug Interactions

Drugs Folate plasma level with adjuvant drugs Drug plasma level with adjuvant high dose folate
Anticonvulsants– first generation: carbamazepine, fosphenytoin, phenytoin, phenobarbital, primidone, valproic acid, valproate
Other Anticonvulsants; lamotrigine
Methotrexate
Alcohol (excess amounts)
Sulfasalazine
Cholestyramine
Colchicine
Colestipol
Isltretinoin
L-Dopa
Methylprednisone
NSAIDs (high dose): ibuprofen, naproxen, indomethacin, sulindac
Oral Contraceptives
Pancreatic enzymes: pancrelipase, pancratin
Pentamidine
Pyrimethamine
Smoking
Triamterene
Trimethoprim

Deplin® (L-methylfolate) is an orally administered medical food for use only under medical supervision for the dietary management of suboptimal folate levels in depressed patients.

Legal Disclaimer
Deplin.com © 2010